-
Published 5/27/2026
Slivnick JA, Lim SC, Randazzo M, Maurer MS, Helmke S, Scherrer-Crosbie M, Vakilpour A, Zareba KM, Goyal A, Cheng R, Wakamatsu N, Kitano T, Takeuchi M, Hotta VT, Vieira MLC, Elissamburu P, Ronderos RE, Prado A, Koutroumpakis E, Deswal A, Pursnani A, Sarswat N, Addetia K, Cotella J, Ruberg FL, Frost M, Fontana M, Lam Su Ping C, Lang RM, Asch FM. Multimodal Artificial Intelligence for Cardiac Amyloidosis Diagnosis: Integrating Echocardiography With Clinical and Laboratory Data for Improved Detection. Circ Cardiovasc Imaging. 2026 May 27; e019610. PMID: 42200278.
-
Published 5/1/2026
Ambardekar AV, Sarswat N, Wright R, Berk J, Davis MK, Garcia-Pavia P, Gillmore JD, Grodin JL, Mitchell JD, Mooney D, Nativi-Nicolau J, Poulsen SH, Ruberg FL, Chen C, Ji A, Siddhanti S, Tamby JF, Castaño A, Katz L, Sinha U, Fox JC, Maurer MS, Cheng RK. Acoramidis, Serum Transthyretin, and Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Trial. J Card Fail. 2026 May; 32(5):864-876. PMID: 42128580.
-
Published 4/29/2026
McMenamin KJ, Teruya S, Slivnick J, Alreshq R, Ullah I, Fine D, Elzieny AA, Helmke S, Gallegos C, Miller EJ, Asch FM, Hasan S, Maurer MS, Ruberg FL. Fully Automated vs. Human Echocardiogram Interpretation in Transthyretin Amyloid Cardiomyopathy: The SCAN-MP Study. J Am Soc Echocardiogr. 2026 Apr 29. PMID: 42066965.
-
Published 4/17/2026
Berumen A, Staron A, Kalaitzidis G, Siddiqi OK, Gopal DM, Ruberg FL, Sanchorawala V. Evaluating AL-ISS within a BNP-Based Model for AL Amyloidosis in the Daratumumab Era. Blood Adv. 2026 Apr 17. PMID: 41995749.
-
Published 2/1/2026
Pandey S, Ruberg FL. A tale of two tracers-does one outperform the other? J Nucl Cardiol. 2026 Feb; 56:102621. PMID: 41771626.